Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-034055

KalVista Pharmaceuticals, Inc. · KALV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Khaled Nasr
10% Owner
Period of report
Apr 14, 2015
Accepted (ET)
Apr 14, 2015 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Apr 14, 2015C831,531—A831,531ISee Footnote
Common StockF1,F2Apr 14, 2015C2,145,351—A2,976,882ISee Footnote
Common StockF3,F2Apr 14, 2015C466,357—A3,443,239ISee Footnote
Common StockF4,F2Apr 14, 2015C365,957—A3,809,196ISee Footnote
Common StockF2Apr 14, 2015P810,000$5.00A4,619,196ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF1,F2—Apr 14, 2015C831,531D——Common Stock831,5310I
Series B Convertible Preferred StockF1,F2—Apr 14, 2015C2,145,351D——Common Stock2,145,3510I
Convertible Promissory NoteF3,F2—Apr 14, 2015C466,357D——Common Stock466,3570I
Convertible Promissory NoteF4,F2—Apr 14, 2015C365,957D——Common Stock365,9570I

Explanation of responses

Remarks

Exhibit List Exhibit 99 - Form 4 Joint Filer Information